M J Biopharm Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1987.
1987 Mumbai, Maharashtra, India Amalgamated
Last Updated:
About M J Biopharm Private Limited

M J Biopharm Private Limited, a amalgamated private limited company, was established on 24 August 1987 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U29249MH1987PTC044458. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹13.01 Cr.

Employing 264 professional, Its leadership includes Amol Jashvant Shah (Managing Director), Dhaval Vipin Vashi (Director). Past directors included Jashvant Mansukhlal Shah, Dhaval Vipin Vashi, Pradyumn Gaurishanker Shrotriya. It holds no open charges and ₹89.62 Cr settled loans. Its latest AGM occurred on 29 September 2017, with the balance sheet filed on 31 March 2017. It is based at 113 Jolly Maker Chambers 2Nariman Point, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U29249MH1987PTC044458

  • Registration Number

    044458

  • Incorporation Date

    24 August 1987

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹13.01 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 13.01 Cr
  • Company Age 38 Year, 5 Months
  • Last Filing with ROC 31 Mar 2017
  • Satisfied Charges ₹ 89.62 Cr
  • Revenue Growth **** 8.69%
  • Profit Growth **** -27.31%
  • Ebitda **** -26.76%
  • Net Worth 9.47%
  • Total Assets **** 10.76%
Company report

M J Biopharm Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into M J Biopharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at M J Biopharm Private Limited?
Current Directors
Name Designation Appointment Date Status
Amol Jashvant Shah Managing Director 03 Dec 1997 Current
Dhaval Vipin Vashi Director 22 Jun 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Alternate Director 21 Apr 2015 Past
Pramod Abcsdd Additional Director 19 Sep 2013 Past
Pramod Abcsdd Director 07 Jan 2009 Past
Pramod Abcsdd Director 22 Jun 2013 Past
Pramod Abcsdd Alternate Director 23 Jan 2017 Past
Pramod Abcsdd Director 07 Oct 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of M J Biopharm.

M J Biopharm Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 8.69% increase. The company also saw a substantial fall in profitability, with a 27.31% decrease in profit. The company's net worth moved up by a moderate rise of 9.47%.

M J Biopharm revenue growth over time
M J Biopharm profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
8.69%
*******
*******
*******
*******
Revenue from Operations
*******
9.80%
*******
*******
*******
*******
Total Assets
*******
10.76%
*******
*******
*******
*******
Profit or Loss
*******
-27.31%
*******
*******
*******
*******
Net Worth
*******
9.47%
*******
*******
*******
*******
EBITDA
*******
-26.76%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of M J Biopharm?

In 2017, M J Biopharm had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹896,152,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 51.12 Cr
  • Abn Amro Bank N. V. : 33.00 Cr
  • Export-Import Bank Of India : 5.50 Cr
Latest Charge Details
Date Lender Amount Status
15 Jan 2009 Abn Amro Bank N. V. ₹14.50 Cr Satisfied
25 Jun 2007 Abn Amro Bank N. V. ₹18.50 Cr Satisfied
17 Aug 2006 Export-Import Bank Of India ₹5.50 Cr Satisfied
28 May 2003 Canara Bank ₹3.50 M Satisfied
12 Mar 2001 Canara Bank ₹0.29 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at M J Biopharm?

M J Biopharm has a workforce of 264 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of M J Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M J Biopharm's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on M J Biopharm
Recent Activity within the Organization
  • Annual General Meeting

    Progress on M J Biopharm Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on M J Biopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was documented.

  • Charges

    Progress on A charge registered on 15 Jan 2009 via Charge ID 10137160 with Abn Amro Bank N. V. was fully satisfied on 06 May 2014. was documented.

  • Charges

    Progress on A charge registered on 25 Jun 2007 via Charge ID 10058726 with Abn Amro Bank N. V. was fully satisfied on 06 May 2014. was documented.

  • Director Appointment

    Dhaval Vipin Vashi was appointed as a Director was appointed as a Director on 22 Jun 2013 & has been associated with this company since 12 years 7 months . was recorded as a recent event.

  • Charges

    The activity A charge registered on 17 Aug 2006 via Charge ID 10014306 with Export-Import Bank Of India was fully satisfied on 29 Aug 2012. was completed.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement
  • M J Biopharm news update on market trends
    Cousins Reunite in Business: Mehli Mistry Invests in MJ Biopharm for Diabetes Treatment.

    When your cousin gets kicked out of Tata Group but you still got his back and invest in MJ Biopharm, a company that makes insulin. Mehli Mistry, Cyrus' cousin, bought a 20% stake in the company through his own business. He's also invested in PNB MetLife insurance and his own company, M Pallonji & Co, is doing well. He's interested in MJ Biopharm because he's diabetic. The company makes other drugs too and has two factories. The diabetes market in India is worth a lot. Mehli and Cyrus used to be cool but then Cyrus wanted to be fair and transparent with contracts and Mehli didn't like that. But they both deny any drama..

    TNN

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of M J Biopharm Private Limited?

The CIN of M J Biopharm Private Limited is U29249MH1987PTC044458.

Where is M J Biopharm Private Limited headquartered?

M J Biopharm Private Limited is headquartered at 113 Jolly Maker Chambers 2Nariman Point, Mumbai, Maharashtra, 400021.

When was M J Biopharm Private Limited incorporated?

M J Biopharm Private Limited was incorporated on 24 August 1987.

Who are the current directors of M J Biopharm Private Limited?

The current directors of M J Biopharm Private Limited are

What is the primary industry of M J Biopharm Private Limited?

The primary industry of M J Biopharm Private Limited is Manufacturing.

Is M J Biopharm Private Limited a listed company?

M J Biopharm Private Limited is unlisted.

What is the capital structure of M J Biopharm Private Limited?

The authorized capital of M J Biopharm Private Limited is ₹20.00 Cr, and the paid-up capital is ₹13.01 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available